SAPONARA, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 9.340
EU - Europa 7.048
AS - Asia 3.674
SA - Sud America 586
AF - Africa 150
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.831
Nazione #
US - Stati Uniti d'America 9.227
GB - Regno Unito 1.402
RU - Federazione Russa 1.362
CN - Cina 1.264
IT - Italia 1.254
SG - Singapore 1.151
IE - Irlanda 840
FR - Francia 513
BR - Brasile 468
SE - Svezia 422
UA - Ucraina 375
VN - Vietnam 363
DE - Germania 343
HK - Hong Kong 284
FI - Finlandia 203
KR - Corea 186
IN - India 115
ZA - Sudafrica 71
CA - Canada 68
TR - Turchia 60
ES - Italia 56
NL - Olanda 50
AR - Argentina 42
BD - Bangladesh 42
AT - Austria 33
JP - Giappone 28
BE - Belgio 27
MX - Messico 26
PL - Polonia 26
BG - Bulgaria 23
CZ - Repubblica Ceca 22
IQ - Iraq 21
AU - Australia 20
EC - Ecuador 20
PK - Pakistan 20
ID - Indonesia 19
NG - Nigeria 19
EE - Estonia 17
MA - Marocco 16
EG - Egitto 13
CO - Colombia 12
LT - Lituania 12
UZ - Uzbekistan 12
IR - Iran 11
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
DK - Danimarca 9
PE - Perù 9
CH - Svizzera 8
KE - Kenya 8
KZ - Kazakistan 8
PH - Filippine 8
SA - Arabia Saudita 8
CI - Costa d'Avorio 7
RO - Romania 7
IL - Israele 6
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RS - Serbia 6
BO - Bolivia 5
EU - Europa 5
OM - Oman 5
PY - Paraguay 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HU - Ungheria 4
KH - Cambogia 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
NO - Norvegia 4
VE - Venezuela 4
AF - Afghanistan, Repubblica islamica di 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
LU - Lussemburgo 3
PA - Panama 3
SN - Senegal 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DZ - Algeria 2
HN - Honduras 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 20.814
Città #
Dallas 2.072
Southend 1.217
Fairfield 880
Dublin 826
Ashburn 785
Singapore 599
Chandler 395
Siena 379
Moscow 370
Santa Clara 363
Woodbridge 354
Houston 348
Seattle 348
Beijing 334
Jacksonville 297
Cambridge 293
Wilmington 290
Hong Kong 270
Ann Arbor 259
San Jose 245
Hefei 201
Seoul 184
Los Angeles 150
Council Bluffs 140
Princeton 132
The Dalles 123
Nanjing 110
Helsinki 108
Florence 105
Ho Chi Minh City 102
Milan 100
Lauterbourg 98
Hanoi 88
New York 85
Munich 77
Boardman 71
Fremont 65
Washington 64
Johannesburg 60
San Mateo 54
Shanghai 54
Columbus 51
San Diego 49
Izmir 45
Bengaluru 43
Menlo Park 40
São Paulo 40
Dearborn 39
Rome 39
Buffalo 38
Nanchang 36
Orem 36
Redondo Beach 36
London 35
Málaga 33
San Francisco 30
Dong Ket 29
Tianjin 29
Frankfurt am Main 28
Brussels 27
Hebei 26
Guangzhou 25
Chicago 24
Turku 23
Haiphong 21
Shenyang 21
Tokyo 21
Vienna 21
Düsseldorf 20
Da Nang 19
Nuremberg 19
Sofia 19
Toronto 19
Abuja 17
Montreal 17
Phoenix 17
Redwood City 16
Brescia 15
Lappeenranta 15
Naples 15
Amsterdam 14
Jinan 14
Ottawa 14
Warsaw 14
Hangzhou 13
Rio de Janeiro 13
Torino 13
Zhengzhou 13
Belo Horizonte 12
Chennai 12
Norwalk 12
Salt Lake City 12
Changsha 11
Jakarta 11
Jiaxing 11
Manchester 11
Mumbai 11
Newcastle 11
Stockholm 11
Atlanta 10
Totale 14.431
Nome #
New dimension of ciprofloxacin hybrids: Synthesis, characterization and anticancer evaluation of newly C3-modified ciprofloxacin derivatives 789
The insulin-releasing agent quercetin-3-oleate stimulates CaV1.2 channels similarly to quercetin, though with a reduced vasorelaxant activity 454
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]- N -[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 402
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 375
Antihypertensive, cardio-and neuroprotective effects of Tenebrio molitor (Coleoptera: Tenebrionidae) defatted larvae in spontaneously hypertensive rats 355
From in silico to in vitro: A trip to reveal flavonoid binding on the Rattus norvegicus Kir6.1 ATP-sensitive inward rectifier potassium channel 343
Negative chronotropism, positive inotropism and lusitropism of 3,5-di-t-butyl-4-hydroxyanisole (DTBHA) on rat heart preparations occur through reduction of RyR2 Ca2+ leak 336
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 310
Functional, electrophysiological and molecular docking analysis of the modulation of Cav 1.2 channels in rat vascular myocytes by murrayafoline A 288
Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies 287
Optimization of 4-Aminoquinoline/Clotrimazole-Based Hybrid Antimalarials: Further Structure-Activity Relationships, in vivo Studies, and Preliminary Toxicity Profiling 272
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 272
The surge of flavonoids as novel, fine regulators of cardiovascular Cav channels 270
Repurposing old drugs to fight multidrug resistant cancers 268
Folate-targeted liposomal nitrooxy-doxorubicin: an effective tool against P-glycoprotein-positive and folate receptor-positive tumors 265
3,5-dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7): a new multidrug resistance inhibitor devoid of effects on Langendorff-perfused rat heart 264
A specific taurine recognition site in the rabbit brain is responsible for taurine effects on thermoregulation 263
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 255
Vasoactivity of Mantonico and Pecorello grape pomaces on rat aorta rings: An insight into nutraceutical development 254
2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) inhibits vascular L-type Ca2+ channel via superoxide anion generation 253
Screening for potential hazard effects from multitarget anthracycline on the cardiovascular system 250
In vitro vascular toxicity of tariquidar, a potential tool for in vivo PET studies 249
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 249
Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile 248
In vitro assessement of tariquidar toxicity towards vasculature 248
New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations 247
(+/-)-Naringenin as large conductance Ca2+-activated K+ (BKCa) channel opener in vascular smooth muscle cells 246
3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility 243
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 241
Cancer cell permeability-glycoprotein as a target of MDR reverters: possible role of novel dihydropyridine derivatives 234
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy 231
The vasodilator papaverine stimulates L-type Ca(2+) current in rat tail artery myocytes via a PKA-dependent mechanism 231
MC225, a novel probe for P-glycoprotein PET Imaging at the blood-brain barrier: in vitro cardiovascular safety evaluation 228
Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes 228
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels 228
Vascular toxicity risk assessment of MC18 and MC70, novel potential diagnostic tools for in vivo PET studies 226
Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery 225
Vascular Toxicity Risk Assessment of MC18 and MC70, Novel Potential Diagnostic Tools for In Vivo PET Studies 221
Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism 220
Mitochondrial-targeting nitrooxy-doxorubicin: effects on P-glycoprotein and assessment of their vascular effects 217
Flavonoids and hERG channels: Friends or foes? 217
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 213
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators 212
Failure Effect Analysis of Patch-Clamp Electronic Instrumentation in Electrophysiology Experiments 211
Effects of taurine and some structurally related analogues on the central mechanism of thermoregulation: a structure-activity relationship study 210
The beneficial health effects of flavonoids on the cardiovascular system: focus on K+ channels 205
Cardamonin is a bifunctional vasodilator that inhibits Cav1.2 current and stimulates KCa1.1 current in rat tail artery myocytes 204
Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy 204
The selective rat toxicant norbormide blocks KATP channels in smooth muscle cells but not in insulin-secreting cells 200
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker 198
Sdox, a H2S releasing anthracycline, with a safer profile than doxorubicin toward vasculature 197
Interference measurements and failure analysis of patch-clamp laboratory instrumentation for electrophysiology tests 195
Vascular activity of two silicon compounds, ALIS 409 and ALIS 421, novel multidrug-resistance reverting agents in cancer cells 193
Artificial intelligence-driven identification of morin analogues acting as CaV1.2 channel blockers: synthesis and biological evaluation 189
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 189
GABA-mediated effects of some taurine derivatives injected i.c.v. on rabbit rectal temperature and gross motor behaviour 189
L-type Ca2+ channel current characteristics are preserved in rat tail artery myocytes after one-day storage 186
The novel potent multidrug resistance inhibitors N,N-bis(cyclohexanol)amine aryl esters are devoid of vascular effects 185
The multi-factorial nature of clinical multidrug resistance in cancer 185
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives 178
Traceability and authentication in agri-food production: A multivariate approach to the characterization of the Italian food excellence elephant garlic (Allium ampeloprasum L.), a vasoactive nutraceutical 173
Effects of some sterically hindered phenols on whole-cell Ca2+ current of guinea pig gastric fundus smooth muscle cells 172
Mechanism of myricetin stimulation of vascular L-type Ca2+ current 170
Relaxant and Ca2+ channel blocking properties of norbormide on rat non-vascular smooth muscles 170
Tyrosine kinase inhibitor Si409 has in vitro and in vivo anti-tumor activity against diffuse large B-cell lymphoma 167
Quercetin as a novel activator of L-type Ca2+ channels in rat tail artery smooth muscle cells 167
Vietnamese Dalbergia tonkinensis: A Promising Source of Mono- and Bifunctional Vasodilators 166
The Enigma of Norbormide, a Rattus-Selective Toxicant 166
L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles 166
Playing with opening and closing of heterocycles: using the Cusmano-Ruccia reaction to develop a novel class of oxadiazolothiazinones, active as calcium channel modulators and p-glycoprotein inhibitors 164
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors 164
Synthesis and antiperoxidant activity of new phenolic O-glycosides 163
Effects of commonly used protein kinase inhibitors on vascular contraction and L-type Ca2+ current 163
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 161
Functional, electrophysiology, and molecular dynamics analysis of quercetin-induced contraction of rat vascular musculature 159
Quercetin antagonism of Bay K 8644 effects on rat tail artery L-type Ca(2+) channels 157
Novel Labdane Diterpenes-Based Synthetic Derivatives: Identification of a Bifunctional Vasodilator That Inhibits CaV1.2 and Stimulates KCa1.1 Channels 156
In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin 153
The flavonoid scaffold as a template for the design of modulators of the vascular Cav1.2 channels 152
Mechanisms of the antispasmodic activity of 3,5-di-t-butyl catechol (DTCAT) on rat vascular smooth muscles 152
Quercetin relaxes rat tail main artery partly via a PKG-mediated stimulation of KCa1.1 channels 148
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents 144
Screening for potential hazardous effects of an H2S-donating anthracycline on the cardiovascular system. 136
Effects of quercetin and rutin on vascular preparations: a comparison between mechanical and electrophysiological phenomena. 136
Vasorelaxant Effects Induced by Red Wine and Pomace Extracts of Magliocco Dolce cv 135
A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound 133
Effects of wine polyphenols on vascular functions: an electro-mechanic investigation. 132
Mechanism of osthole inhibition of vascular Cav1.2 current 130
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients 129
Screening of the antioxidant and vasorelaxant activity of wine waste ultrasonic extracts, and HRMS targeted and semi-targeted profiling of glycosylated polyphenols vs free polyphenols 127
Freeze-dried red wine effects on cardiac function and ECG of the Langendorff-perfused rat heart 127
Nutritionally enriched tomatoes (Solanum lycopersicum L.) grown with wood distillate: chemical and biological characterization for quality assessment 126
Ritanserin blocks CaV1.2 channels in rat artery smooth muscles: electrophysiological, functional, and computational studies 124
Inhibition of iron-dependent decomposition of H2O2 as a method for assessing the free-radical-scavenging activity of novel antioxidants in a hydrophilic environment. 108
null 106
Wine Lees as Source of Antioxidant Molecules: Green Extraction Procedure and Biological Activity 103
null 103
Hypoxia as a driver of resistance to immunotherapy 92
PERTRAS observational study: clinical and economic analysis of trastuzumab plus neoadjuvant pertuzumab in women with HER-2 positive breast cancer. [Studio osservazionale PERTRAS: analisi clinica ed economica di trastuzumab più pertuzumab neoadiuvante in donne con carcinoma mammario HER-2 positivo] 89
Off-label use of hydroxychloroquine in COVID-19: analysis of reports of suspected adverse reactions from the Italian National Network of Pharmacovigilance 78
Totale 20.912
Categoria #
all - tutte 63.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 0 0 0 144 121
2021/20221.489 104 188 117 101 65 60 107 55 109 163 155 265
2022/20231.747 109 154 248 258 121 313 69 152 174 55 66 28
2023/20241.689 78 30 183 80 114 480 457 31 6 44 42 144
2024/20253.061 81 138 267 189 369 195 187 218 282 152 314 669
2025/20267.251 550 1.685 1.125 725 1.248 259 749 236 276 385 13 0
Totale 21.151